Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc.

新泽西州 - Citius Oncology, Inc. (NASDAQ: CTOR )周五宣布，该公司已实施一个人工智能平台，以增强其商业运营，为预期推出的皮肤T细胞淋巴瘤 (CTCL)治疗药物LYMPHIR做准备。母公司Citius Pharmaceuticals (NASDAQ: CTXR )目前交易价格为$1.23，根据 InvestingPro ...

Markets regulator Securities and Exchange Board of India (SEBI) has imposed a penalty of Rs2 lakh on SMC Global Securities ...

Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech & pharma.

DelveInsight's HDAC Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

爸爸带娃丝滑漂移，动作简直太丝滑，宝宝：你觉得我想玩吗 ...

谷歌研究团队提出了一种新型的隐私保护合成数据生成算法CTCL，能够在保证隐私的前提下自动生成高质量的合成数据。这项技术不仅减少了计算负担，还提高了数据生成的质量和效率。 近日，谷歌研究人员在ICML 2025会议上展示了他们的最新成果——一种名为CTCL（Data Synthesis with ConTrollability and ...

Q2 2025 Earnings Call Transcript August 13, 2025 STRATA Skin Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.6 EPS, expectations were $-0.24. Operator: Ladies and gentlemen, thank ...

Soligenix (NASDAQ: SNGX) , a late-stage biopharma company developing treatments for rare diseases, reported Q2 2025 results and recent milestones. Th ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...